Paper36207293
A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer.
Kim M and 14 others. Oncogenesis, 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer. Papers, record 36207293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36207293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| BC200469 | U.S. Department of Defense (United States Department of Defense) | PubMed | PubMed | ||
| R01GM112722 | U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (National Cancer Institute Division of Cancer Epidemiology and Genetics) | R01GM112722 | PubMed | NIH RePORTER |
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18250154 | Identification of ZBP-89 as a novel GATA-1-associated transcription factor involved in megakaryocytic and erythroid development. | Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18250154 | PubMed |
| 2 | 24338721 | Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer. | Int J Biol Markers | 2013 | https://conductscience.org/library/papers/24338721 | PubMed |
| 3 | 31409851 | BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling. | Sci Rep | 2019 | https://conductscience.org/library/papers/31409851 | PubMed |
| 4 | 29062075 | Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. | Sci Rep | 2017 | https://conductscience.org/library/papers/29062075 | PubMed |
| 5 | 12065315 | Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. | Circ Res | 2002 | https://conductscience.org/library/papers/12065315 | PubMed |
| 6 | 12718878 | A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. | Mol Cell | 2003 | https://conductscience.org/library/papers/12718878 | PubMed |
| 7 | 22522925 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. | Nature | 2012 | https://conductscience.org/library/papers/22522925 | PubMed |
| 8 | 18048329 | ID genes mediate tumor reinitiation during breast cancer lung metastasis. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/18048329 | PubMed |
| 9 | 28427212 | High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer. | Oncotarget | 2017 | https://conductscience.org/library/papers/28427212 | PubMed |
| 10 | 29527331 | Targeting oncogenic Myc as a strategy for cancer treatment. | Signal Transduct Target Ther | 2018 | https://conductscience.org/library/papers/29527331 | PubMed |
| 11 | 19325547 | Use of in vivo biotinylation to study protein-protein and protein-DNA interactions in mouse embryonic stem cells. | Nat Protoc | 2009 | https://conductscience.org/library/papers/19325547 | PubMed |
| 12 | 31324052 | Targeting Cancer Stem Cells in Triple-Negative Breast Cancer. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31324052 | PubMed |
| 13 | 16049480 | Genes that mediate breast cancer metastasis to lung. | Nature | 2005 | https://conductscience.org/library/papers/16049480 | PubMed |
| 14 | 32714745 | SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFR. | Adv Sci (Weinh) | 2020 | https://conductscience.org/library/papers/32714745 | PubMed |
| 15 | 28122577 | The Id-protein family in developmental and cancer-associated pathways. | Cell Commun Signal | 2017 | https://conductscience.org/library/papers/28122577 | PubMed |
| 16 | 28951456 | MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer. | Cancer Res | 2017 | https://conductscience.org/library/papers/28951456 | PubMed |
| 17 | 32512343 | ZNF281-miR-543 Feedback Loop Regulates Transforming Growth Factor-β-Induced Breast Cancer Metastasis. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/32512343 | PubMed |
| 18 | 10899165 | Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10899165 | PubMed |
| 19 | 29471829 | Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer. | Mol Cancer | 2018 | https://conductscience.org/library/papers/29471829 | PubMed |
| 20 | 27161491 | The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. | Nat Commun | 2016 | https://conductscience.org/library/papers/27161491 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42691507 | In vivo and FACS-based CRISPR/Cas9 screening uncovers VENTX as a crucial element in maintaining seminoma stemness. | Transl Oncol | 2026 | https://conductscience.org/library/papers/42691507 | PubMed |
| 42558564 | Inhibitor of DNA binding 1 in lung cancer and the tumor microenvironment: a testable hypothesis for malignant pleural effusion formation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42558564 | PubMed |
| 41991908 | PD-1/LAG-3 signaling rewires T-cells via MYC inhibition. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41991908 | PubMed |
| 41476491 | Interplay between Epigenetic and Transcription Factors Mediating Drug Resistance via Stem Cells in Breast Cancer. | ACS Omega | 2025 | https://conductscience.org/library/papers/41476491 | PubMed |
| 41457142 | The ZNF148-ZEB1-AS1-IGF2BP2-NOD2 Axis Drives Microglial Antipneumococcal Immunity in Bacterial Meningitis. | Glia | 2026 | https://conductscience.org/library/papers/41457142 | PubMed |
| 40732268 | Beyond the Limit: MYC Mediates Tumor Immune Escape. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40732268 | PubMed |
| 40640173 | Exploring ID4 as a driver of aggression and a therapeutic target in triple-negative breast cancer. | NPJ Breast Cancer | 2025 | https://conductscience.org/library/papers/40640173 | PubMed |
| 39614338 | Gremlin-2 is a novel tumor suppressor that negatively regulates ID1 in breast cancer. | Breast Cancer Res | 2024 | https://conductscience.org/library/papers/39614338 | PubMed |
| 39567716 | Spatial multiomic landscape of the human placenta at molecular resolution. | Nat Med | 2024 | https://conductscience.org/library/papers/39567716 | PubMed |
| 38297280 | ZNF148 inhibits HBV replication by downregulating RXRα transcription. | Virol J | 2024 | https://conductscience.org/library/papers/38297280 | PubMed |
| 38247819 | Interconversion of Cancer Cells and Induced Pluripotent Stem Cells. | Cells | 2024 | https://conductscience.org/library/papers/38247819 | PubMed |
| 38045173 | CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26). | Heliyon | 2023 | https://conductscience.org/library/papers/38045173 | PubMed |
| 37370820 | Spatial Transcriptomics Identifies Expression Signatures Specific to Lacrimal Gland Adenoid Cystic Carcinoma Cells. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37370820 | PubMed |
| 37118827 | Genome-wide analysis reveals Hsf1 maintains high transcript abundance of target genes controlled by strong constitutive promoter in Saccharomyces cerevisiae. | Biotechnol Biofuels Bioprod | 2023 | https://conductscience.org/library/papers/37118827 | PubMed |
Genes26
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36207293
GET https://conductscience.org/api/papers/v1/36207293/references?page=2